MAPT and Alzheimer disease: While amyloid and tau-genic hypotheses provide important insight into preclinical AD models (Bloom, 2014; Gotz et al., 2001; Ittner and Gotz, 2011; Lewis et al., 2001), vascular dysregulation occurs prior to this AD pathophysiology (Iturria-Medina et al., 2016).